Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Usana Health SciencesUSNA -1.25%66 EV-to-FCF is 104.99 as of Jul. 21, 2026, which is 762% above its 10-year median of 12.18. GuruFocus rates USNA with a GF Score™ of 66/100 and a GF Value™ of $41.43 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,190 Consumer Packaged Goods companies, Usana Health Sciences ranks worse than 92.44% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Usana Health Sciences's Enterprise Value is $310.9 Mil.
Usana Health Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $3.0 Mil. Therefore, Usana Health Sciences's EV-to-FCF for today is 104.99.
The historical rank and industry rank for Usana Health Sciences's EV-to-FCF or its related term are showing as below:
USNA'
s EV-to-FCF Range Over the Past 10 Years
Min: 4.15 Med: 12.18 Max: 106.74
Current: 104.99
During the past 13 years, the highest EV-to-FCF of Usana Health Sciences was 106.74. The lowest was 4.15. And the median was 12.18.
USNA's EV-to-FCF is ranked worse than 92.44% of 1190
companies
in the Consumer Packaged Goods industry
Industry Median: 16.105
vs USNA: 104.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Usana Health Sciences (NYSE:USNA) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Usana Health Sciences's PE Ratio (TTM) for today is calculated as:
Usana Health Sciences's share price for today is $22.12.
Usana Health Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.470.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Usana Health Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Usana Health Sciences EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's EV-to-FCF falls into.
Usana Health Sciences's current Enterprise Value is $310.9 Mil.
Usana Health Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences (USNA) has a EV-to-FCF of 104.99 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Usana Health Sciences and its competitors. This is 762% above median its historical median of 12.18. Over the past decade, Usana Health Sciences' EV-to-FCF has ranged from 4.15 to 106.74. According to the industry distribution chart, Usana Health Sciences ranks #1100 out of 1190 companies in the Consumer Packaged Goods industry, placing it in the top 92.4%.
Is Usana Health Sciences' EV-to-FCF too high?
Usana Health Sciences' current EV-to-FCF of 104.99 is 762% above median its 10-year median of 12.18. Over the past 10 years, this metric has ranged from a low of 4.15 to a high of 106.74. The Consumer Packaged Goods industry median EV-to-FCF is 16.11. Usana Health Sciences' value of 104.99 is 551.9% above this industry median. Based on the distribution chart, Usana Health Sciences ranks #1100 out of 1190 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Usana Health Sciences has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Usana Health Sciences' EV-to-FCF compare to NATR and ENHA?
According to the Consumer Packaged Goods industry distribution chart, Usana Health Sciences ranks #1100 out of 1190 companies for EV-to-FCF. This places Usana Health Sciences in the lower half of its industry. The industry median EV-to-FCF is 16.11. Usana Health Sciences' value of 104.99 is 551.9% above this benchmark. Historically, Usana Health Sciences' own EV-to-FCF has ranged from 4.15 to 106.74 over the past decade. While the company's 10-year median is 12.18 vs. the industry median of 16.11, Usana Health Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 16.11, based on 1,190 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Usana Health Sciences's current EV-to-FCF of 104.99 is 551.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Usana Health Sciences and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 16.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Usana Health Sciences's current EV-to-FCF is 104.99, which is 762% above median its own 10-year median of 12.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Usana Health Sciences stock overvalued right now?
Based on GuruFocus' analysis, Usana Health Sciences (USNA) is currently considered Possible Value Trap. The stock's GF Value™ is $41.43, compared to a current price of $22.12 — trading 46.6% below its estimated fair value. The current EV-to-FCF is 104.99, which is 762% above median its 10-year median of 12.18 and 551.9% above the Consumer Packaged Goods industry median of 16.11. Usana Health Sciences' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Usana Health Sciences (USNA), the current EV-to-FCF is 104.99 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Usana Health Sciences (USNA) Overvalued in 2026?
Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued.
The current stock price of $22.12 is trading 46.6% below its estimated GF Value™ of $41.43.
GuruFocus considers Usana Health Sciences to be Possible Value Trap.
Key valuation signals for USNA:
EV-to-FCF: 104.99 (762% above median its 10-year median of 12.18)
GF Value™: $41.43 vs. price of $22.12 (46.6% below fair value)
Industry Position: 551.9% above the Consumer Packaged Goods median (#1100 of 1190)
No single metric tells the full story. See the USNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
66GF Score
Get the complete analysis for USNA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
USNA has been successfully added to your 
